United States · FDA National Drug Code directory
Ganirelix Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 78206-138_8e2e2cd7-1d83-4f9f-85be-d047bf413f98
- Product NDC
- 78206-138
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Ganirelix Acetate
- Labeler
- Organon LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210601
- Source listing expiry
- 20261231
Source-listed ingredients
- GANIRELIX ACETATE — 250 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (78206-138-01) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS · 78206-138-01
- 1 BLISTER PACK in 1 CARTON (78206-138-02) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS · 78206-138-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →